Correlations between BCL6 rearrangement and outcome in patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP | Haematologica
TP53 mutation and survival in aggressive B cell lymphoma - Zenz - 2017 - International Journal of Cancer - Wiley Online Library
PDF) Correlations between BCL6 rearrangement and outcome in patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP
PDF) Pharmacological restoration and therapeutic targeting of the B-cell phenotype in classical Hodgkin lymphoma
Stephan MATHAS | Charité Universitätsmedizin Berlin, Berlin | Charité | Medical Department, Division of Hematology, Oncology and Tumor Immunology
CD30 expression in de novo diffuse large B‐cell lymphoma: a population‐based study from British Columbia - Slack - 2014 - British Journal of Haematology - Wiley Online Library
Hodgkin lymphoma: 2016 update on diagnosis, risk‐stratification, and management - Ansell - 2016 - American Journal of Hematology - Wiley Online Library
Genomic and epigenomic co-evolution in follicular lymphomas | Leukemia
Constitutively overexpressed 21 kDa protein in Hodgkin lymphoma and aggressive non-Hodgkin lymphomas identified as cytochrome B5b (CYB5B) | SpringerLink
Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma | NEJM
CD30 expression in de novo diffuse large B‐cell lymphoma: a population‐based study from British Columbia - Slack - 2014 - British Journal of Haematology - Wiley Online Library
Gene expression profiling defines molecular subtypes of classical Hodgkin's disease | Oncogene
Constitutively overexpressed 21 kDa protein in Hodgkin lymphoma and aggressive non-Hodgkin lymphomas identified as cytochrome B5b (CYB5B) | SpringerLink
Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma | NEJM
Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma | NEJM
CQSE: Our Team
Horst HUMMEL | University of Wuerzburg, Würzburg | JMU | Department of Internal Medicine II
Constitutively overexpressed 21 kDa protein in Hodgkin lymphoma and aggressive non-Hodgkin lymphomas identified as cytochrome B5b (CYB5B) | SpringerLink
Sequential karyotyping in Burkitt lymphoma reveals a linear clonal evolution with increase in karyotype complexity and a high frequency of recurrent secondary aberrations - Aukema - 2015 - British Journal of Haematology - Wiley Online Library
PDF) Macrophages predict treatment outcome in Hodgkin's lymphoma
Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma | NEJM
Development of Traceable Rituximab-Modified PEO-Polyester Micelles by Postinsertion of PEG-phospholipids for Targeting of B-cell Lymphoma,ACS Omega - X-MOL
Horst HUMMEL | University of Wuerzburg, Würzburg | JMU | Department of Internal Medicine II
